All three cited senate.gov sources are real, live, and accurately quoted; each supports the outcome. Independently re-verified: (1) As Ranking Member of the Senate Appropriations Labor-HHS Subcommittee, Capito authored the FY2024 Labor-HHS bill carrying a $100M increase for Alzheimer's/dementia research ($10M NINDS + $90M NIA) plus $128,323,000 in Congressionally Directed Spending for 64 WV health/education initiatives (confirmed via capito.senate.gov and appropriations.senate.gov). (2) She became Chair of that same subcommittee for the 119th Congress (2025), personally leading the FY2026 Labor-HHS bill (Committee advanced 26-3), which third-party groups (ASCO, ACS CAN) applauded for INCREASING NIH/NCI funding rather than cutting it. (3) On cancer, she authored the bipartisan Childhood Cancer STAR Act (reauthorized/signed 2023; ~$120M delivered to date; $30M for the Act in the FY2026 NCI line). (4) On addiction, she 'played an influential role in crafting the SUPPORT for Patients and Communities Act, the largest comprehensive addiction response legislation ever,' plus HEAL/SUD funding in her bills. This is sustained leadership driving the exact named priorities, far beyond a single supporting vote, so it exceeds ATTEMPTED/PARTIAL. Because the promise is an ongoing pursuit (cures are not achievable in this window), FULL does not apply and CHAMPIONED is correct. Adversarial fairness check: a senator of either party who chairs the appropriations subcommittee funding these exact priorities AND authors the relevant disease-specific legislation would earn CHAMPIONED under the same standard; no partisan leniency detected. No counter-evidence of working against the priorities was found (her FY2026 committee bill actually resisted proposed NIH cuts). Confidence 0.9 reflects strong, multiply-corroborated primary evidence against a broadly worded promise.